ESNT vs. SYNT, TET, ZTF, ELM, VCT, RSG, PAF, IBST, TKO, and ATYM
Should you be buying Essentra stock or one of its competitors? The main competitors of Essentra include Synthomer (SYNT), Treatt (TET), Zotefoams (ZTF), Elementis (ELM), Victrex (VCT), Resolute Mining (RSG), Pan African Resources (PAF), Ibstock (IBST), Taseko Mines (TKO), and Atalaya Mining (ATYM). These companies are all part of the "basic materials" sector.
Essentra (LON:ESNT) and Synthomer (LON:SYNT) are both small-cap basic materials companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, analyst recommendations, valuation, media sentiment, profitability, earnings, risk and community ranking.
Essentra has higher earnings, but lower revenue than Synthomer. Synthomer is trading at a lower price-to-earnings ratio than Essentra, indicating that it is currently the more affordable of the two stocks.
In the previous week, Synthomer had 2 more articles in the media than Essentra. MarketBeat recorded 2 mentions for Synthomer and 0 mentions for Essentra. Synthomer's average media sentiment score of 0.30 beat Essentra's score of 0.00 indicating that Synthomer is being referred to more favorably in the news media.
119.5% of Essentra shares are held by institutional investors. Comparatively, 25.6% of Synthomer shares are held by institutional investors. 4.3% of Essentra shares are held by insiders. Comparatively, 27.1% of Synthomer shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
Synthomer received 367 more outperform votes than Essentra when rated by MarketBeat users. However, 72.56% of users gave Essentra an outperform vote while only 68.50% of users gave Synthomer an outperform vote.
Essentra has a net margin of 1.71% compared to Synthomer's net margin of -3.40%. Essentra's return on equity of 1.71% beat Synthomer's return on equity.
Essentra presently has a consensus target price of GBX 300, indicating a potential upside of 69.80%. Synthomer has a consensus target price of GBX 224.40, indicating a potential downside of 14.23%. Given Essentra's stronger consensus rating and higher probable upside, equities analysts plainly believe Essentra is more favorable than Synthomer.
Essentra pays an annual dividend of GBX 4 per share and has a dividend yield of 2.3%. Synthomer pays an annual dividend of GBX 25 per share and has a dividend yield of 9.6%. Essentra pays out 20,000.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Synthomer pays out -2,083.3% of its earnings in the form of a dividend. Synthomer is clearly the better dividend stock, given its higher yield and lower payout ratio.
Essentra has a beta of 1.19, suggesting that its share price is 19% more volatile than the S&P 500. Comparatively, Synthomer has a beta of 1.78, suggesting that its share price is 78% more volatile than the S&P 500.
Summary
Essentra beats Synthomer on 11 of the 20 factors compared between the two stocks.
Get Essentra News Delivered to You Automatically
Sign up to receive the latest news and ratings for ESNT and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ESNT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Essentra Competitors List
Related Companies and Tools
